Copyright
©The Author(s) 2025.
World J Stem Cells. Jan 26, 2025; 17(1): 97905
Published online Jan 26, 2025. doi: 10.4252/wjsc.v17.i1.97905
Published online Jan 26, 2025. doi: 10.4252/wjsc.v17.i1.97905
Table 1 Summary of different mesenchymal stem cell types in endometrial injury treatment
MSC type | Source | Mechanisms in endometrial repair | Key findings in endometrial injury studies | Ref. |
Umbilical cord-derived MSCs | Endometrium | Proliferation, anti-fibrosis, angiogenesis | Support for endometrial regeneration by differentiating into functional endometrial cells | [85] |
Bone marrow-derived MSCs | Bone marrow | Anti-inflammation, immunomodulation | Reduction of fibrosis and improvement in endometrial thickness and vascularization in preclinical models | [86] |
Adipose tissue-derived MSCs | Adipose tissues | Paracrine signaling, anti-apoptosis | Significant potential in mitigating fibrosis and enhancing cellular regeneration | [87] |
Amniotic MSCs | Amniotic membranes | Immunomodulation, anti-fibrosis | Success in reducing inflammation and supporting tissue repair of the endometrium in experimental settings | [88] |
Menstrual blood-derived MSCs | Menstrual blood | Angiogenesis, epithelial-mesenchymal transition | Known for high proliferative potential and efficacy in improving endometrial receptivity and vascular repair | [89] |
- Citation: Zhang WY, Wang HB, Deng CY. Advances in human umbilical cord mesenchymal stem cells-derived extracellular vesicles and biomaterial assemblies for endometrial injury treatment. World J Stem Cells 2025; 17(1): 97905
- URL: https://www.wjgnet.com/1948-0210/full/v17/i1/97905.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i1.97905